Stockscreener 앱 받기
72.40
0.32%
0.23
시간 외 거래:
72.41
0.010
+0.01%
전일 마감가:
$72.17
열려 있는:
$72.23
하루 거래량:
2.01M
Relative Volume:
0.43
시가총액:
$11.28B
수익:
$1.21B
순이익/손실:
$109.52M
주가수익비율:
103.99
EPS:
0.6962
순현금흐름:
$269.60M
1주 성능:
+0.15%
1개월 성능:
+1.64%
6개월 성능:
+20.81%
1년 성능:
+34.72%
1일 변동 폭
$72.07
$72.42
1주일 범위
$72.00
$72.42
52주 변동 폭
$43.20
$72.42
바이오-테크네 Stock (TECH) Company Profile
명칭
Bio Techne Corp
전화
612-379-8854
주소
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Compare TECH vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
72.40 | 11.25B | 1.21B | 109.52M | 269.60M | 0.6962 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
바이오-테크네 Stock (TECH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2025-07-09 | 개시 | TD Cowen | Buy |
| 2025-05-30 | 개시 | Wells Fargo | Overweight |
| 2025-04-09 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-08 | 개시 | Scotiabank | Sector Outperform |
| 2024-02-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-08-28 | 개시 | William Blair | Outperform |
| 2023-01-10 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | 업그레이드 | Stifel | Hold → Buy |
| 2021-01-25 | 재확인 | The Benchmark Company | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-07-15 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-05-14 | 개시 | The Benchmark Company | Buy |
| 2020-01-08 | 재개 | Stephens | Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-02 | 업그레이드 | Janney | Neutral → Buy |
| 2019-01-14 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-10-17 | 개시 | Goldman | Neutral |
| 2018-06-15 | 개시 | Argus | Buy |
| 2017-07-13 | 개시 | Wells Fargo | Market Perform |
| 2017-02-09 | 개시 | Citigroup | Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Buy |
| 2016-11-10 | 재개 | Leerink Partners | Outperform |
| 2015-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2013-09-20 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
모두보기
바이오-테크네 주식(TECH)의 최신 뉴스
S&CO Inc. Buys Shares of 76,614 Bio-Techne Corp $TECH - marketbeat.com
Bio-Techne Corp (TECH) Stock News Today - TradingKey
Wells Fargo Initiates Bio-Techne(TECH.US) With Hold Rating, Announces Target Price $73 - moomoo.com
Bio-Techne (NASDAQ:TECH) Downgraded to Equal Weight Rating by Wells Fargo & Company - marketbeat.com
Bio-Techne (NASDAQ:TECH) Dividend Move Sparks Fresh Attention - Kalkine Media
TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises - Yahoo Finance
Bio-Techne Corp (NASDAQ:TECH) to Issue Dividend Increase$0.65 Per Share - marketbeat.com
Bio-Techne Corrects Dividend Announcement - Yahoo Finance
Bio-Techne Corp to Issue Quarterly Dividend of $0.08 (NASDAQ:TECH) - marketbeat.com
Bio-Techne (NASDAQ:TECH) Releases Earnings Results, Meets Estimates - MarketBeat
Bio-Techne earnings matched, revenue topped estimates - Investing.com
Bio-Techne Announces Q4 and Full Fiscal Year 2026 Financial Results Alongside Cash Dividend Declaration - Kalkine Media
Bio-Techne Q4 Results: Sales rise 1.33% YoY, beat estimates - scanx.trade
Bio-Techne Releases Fourth Quarter Fiscal 2026 Results - investingnews.com
TECH Looks 1.1% Undervalued on GF Value™ Amid High P/E and Mixed Guru Activity - GuruFocus
Techne (TECH) Q4 Earnings Meet Estimates - Yahoo Finance
Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 Sales - Yahoo Finance
Bio-Techne earnings matched, revenue topped estimates By Investing.com - Investing.com South Africa
Bio-Techne beats revenue estimates on research, diagnostics demand uptick - finance.yahoo.com
Bio-Techne declares $0.08 quarterly dividend - Investing.com
Form 8K Bio-Techne Corp For: 12 August By Investing.com - Investing.com Australia
Is Bio-Techne Corp (TECH) Undervalued After Q4 Earnings Beat? GA - GuruFocus
Bio-Techne reports in-line Q4 earnings, beats on revenue - Investing.com
Bio-Techne reports in-line Q4 earnings, beats on revenue By Investing.com - Investing.com India
Bio-Techne Q4 FY2026 earnings: Organic revenue grows 3% as adjusted EPS slips - TradingKey
Bio-Techne Q4 Revenue Rises to $321.2 Million - Quiver Quantitative
Merck's planned $11.3B acquisition of Bio-Techne moves forward - Stock Titan
Bio-Techne Corp $TECH Stake Decreased by Bank of America Corp DE - MarketBeat
Bio-Techne (TECH) accepts $73-per-share all-cash buyout from Merck KGaA - Stock Titan
Bio-Techne faces quarterly earnings test with Merck deal pending By Investing.com - Investing.com UK
Bio-Techne faces quarterly earnings test with Merck deal pending - Investing.com
Bio-Techne (NASDAQ:TECH) Reaches New 12-Month HighShould You Buy? - marketbeat.com
Bio-Techne Corp (TECH) Stock Analysis: Navigating an 11 Billion Dollar Market Cap Amid Modest Growth Challenges - DirectorsTalk Interviews
Bio-Techne Corp (TECH) Stock Analysis & Forecast - TradingKey
Is Bio-Techne (TECH) Above Fair Value After A 44% Return? - Yahoo Finance
Amundi Sells 148,342 Shares of Bio-Techne Corp $TECH - MarketBeat
The Manufacturers Life Insurance Company Sells 39,950 Shares of Bio-Techne Corp $TECH - marketbeat.com
Investor Trust in Bio-Techne Corp. (TECH) Rises with Easing Headwinds - AlphaStreet
FMR LLC discloses 8.1% Bio-Techne Corp (TECH) holding in amended 13G - Stock Titan
Investors’ Confidence in Bio-Techne Corp. (TECH) Strengthens as Headwind Eases - Yahoo Finance
California State Teachers Retirement System Grows Holdings in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (TECH) Stock Analysis: Exploring Growth Potential Amidst Analyst Consensus - DirectorsTalk Interviews
Bio-Techne Corp $TECH Shares Sold by Segall Bryant & Hamill LLC - marketbeat.com
Form 4 Bio-Techne Corp For: 31 July By Investing.com - Investing.com Nigeria
Quantinno Capital Management LP Reduces Position in Bio-Techne Corp $TECH - marketbeat.com
BIO-TECHNE Corp (NASDAQ: TECH) CEO exercises 35,000 options, 28,686 shares withheld - Stock Titan
Bio-Techne's Q4 Earnings on Deck: What's in Store for the Stock? - TradingView
Dimensional Fund Advisors LP Boosts Holdings in Bio-Techne Corp $TECH - marketbeat.com
Bio-Techne Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Bio-Techne (NASDAQ:TECH) Sets New 52-Week HighShould You Buy? - marketbeat.com
Bio-Techne Corp (TECH) SVP option exercise and share withholding - Stock Titan
바이오-테크네 (TECH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.07%
자본화:
|
볼륨(24시간):